title: [High prevalence of vitamin D deficiency in postmenopausal women at a rheumatology office in Madrid. Evaluation of 2 vitamin D prescription regimens].
abstract: BACKGROUND
  Vitamin D deficiency has been frequently observed in the elderly population in Europe. However few information is available about the vitamin D status in postmenopausal women in the Mediterranean countries. The aim of this study was to evaluate the vitamin D status assessed by serum 25(OH)D3 (calcidiol) in postmenopausal women who attended a Rheumatology practice in Madrid area, and to evaluate calcidiol serum levels through one year after two forms of vitamin D administration.
  
  
  METHODS
  Calcidiol serum levels were measured in 171 postmenopausal women (111 with osteoporosis and 60 without osteoporosis). 82 women with calcidiol serum levels < 10 ng/ml were distributed in two groups: Group I received 800 U/day of vitamin D3 associated with calcium (1 g/day) and group II, one dose of 80,000 U vitamin D orally as calcidiol and latter a daily dose of 800 U vitamin D3 plus 1 g calcium. Calcidiol serum levels were measured by RIA in both groups at basal condition and after three, six and twelve months under treatment.
  
  
  RESULTS
  Three cut-offs were considered: 10, 15 and 20 ng/ml of calcidiol. Percentages of postmenopausal women with vitamin D deficiency for such cut-offs were: 35.3%, 64.1% and 87.1%, respectively. After three months of treatment, women from group II showed calcidiol serum levels higher than group I. At six and twelve months calcidiol serum levels were similar in both groups.
  
  
  CONCLUSIONS
  A high prevalence of vitamin D deficiency was observed in a group of postmenopausal women who attended a rheumatology practice in Madrid area. Both forms of vitamin D administration seem not sufficient to maintain the adequate calcidiol serum levels in postmenopausal deficient women. A dose of 80,000 U of calcidiol twice a year should be considered.
authors.affiliation: Servicio de Reumatología, Hospital Universitario La Paz, Madrid.
authors.forename: P
authors.initials: P
authors.lastname: Aguado
authors.forename: M V
authors.initials: MV
authors.lastname: Garcés
authors.forename: M L
authors.initials: ML
authors.lastname: González Casaús
authors.forename: M T
authors.initials: MT
authors.lastname: del Campo
authors.forename: P
authors.initials: P
authors.lastname: Richi
authors.forename: J
authors.initials: J
authors.lastname: Coya
authors.forename: A
authors.initials: A
authors.lastname: Torrijos
authors.forename: J
authors.initials: J
authors.lastname: Gijón
authors.forename: E
authors.initials: E
authors.lastname: Martín Mola
authors.forename: M E
authors.initials: ME
authors.lastname: Martínez
mesh_terms: D000368:Aged; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008875:Middle Aged; D017698:Postmenopause; D015995:Prevalence; D012219:Rheumatology; D013030:Spain; D014807:Vitamin D / Q000008:administration & dosage*; D014808:Vitamin D Deficiency / Q000188:drug therapy* / Q000453:epidemiology*
chemical_list: D014807:Vitamin D